Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trial.
已完结
10
由 用户3O4EwG 发布于 2026-10-16 10:55
作者:
James Wassil, Jeff Fairman, Carlos A Fierro, James Clark, Sean Bennett, Derek Johnson, Qin Jiang, Thi-Sau Migone, Alexandra Paschenko, Jakub K Simon, Steve Lamola, Maggie Sisti
文献类型:
期刊论文
补充材料:
只需要正文
Elsevier
应助信息
感谢使用文献港
本站所有文献仅供个人学习和参考,请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。